Cell therapy for neurological disorders: Progress towards an embryonic medial ganglionic eminence progenitor-based treatment.
Cell therapy for neurological disorders: Progress towards an embryonic medial ganglionic eminence progenitor-based treatment.
复制标题
DOI:
10.3389/fnins.2023.1177678
复制
发表时间:
2023
影响因子:
4.3
通讯作者:
Baraban, Scott C.
中科院分区:
文献类型:
--
作者:
Righes Marafiga, Joseane;Baraban, Scott C.
Impairment of development, migration, or function of inhibitory interneurons are key features of numerous circuit-based neurological disorders, such as epilepsy. From a therapeutic perspective, symptomatic treatment of these disorders often relies upon drugs or deep brain stimulation approaches to provide a general enhancement of GABA-mediated inhibition. A more effective strategy to target these pathological circuits and potentially provide true disease-modifying therapy, would be to selectively add new inhibitory interneurons into these circuits. One such strategy, using embryonic medial ganglionic (MGE) progenitor cells as a source of a unique sub-population of interneurons, has already proven effective as a cell transplantation therapy in a variety of preclinical models of neurological disorders, especially in mouse models of acquired epilepsy. Here we will discuss the evolution of this interneuron-based transplantation therapy in acquired epilepsy models, with an emphasis on the recent adaptation of MGE progenitor cells for xenotransplantation into larger mammals.
登录
查看更多内容
影响因子:
5.9
作者:
Allison T;Langerman J;Sabri S;Otero-Garcia M;Lund A;Huang J;Wei X;Samarasinghe RA;Polioudakis D;Mody I;Cobos I;Novitch BG;Geschwind DH;Plath K;Lowry WE
通讯作者:
Lowry WE
影响因子:
5.6
作者:
CAVALHEIRO, EA;LEITE, JP;TURSKI, L
通讯作者:
TURSKI, L
影响因子:
2.5
作者:
Howard, MacKenzie A.;Baraban, Scott C.
通讯作者:
Baraban, Scott C.
影响因子:
16.2
作者:
Cobos, Inma;Borello, Ugo;Rubenstein, John L. R.
通讯作者:
Rubenstein, John L. R.
影响因子:
5.3
作者:
Casalia, Mariana L.;Li, Tina;Baraban, Scott C.
通讯作者:
Baraban, Scott C.